Zebrafish Avatars: Toward Functional Precision Medicine in Low-Grade Serous Ovarian Cancer.

functional precision medicine low-grade serous ovarian cancer zAvatars zebrafish xenografts

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 May 2024
Historique:
received: 20 03 2024
revised: 30 04 2024
accepted: 04 05 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

Ovarian cancer (OC) is an umbrella term for cancerous malignancies affecting the ovaries, yet treatment options for all subtypes are predominantly derived from high-grade serous ovarian cancer, the largest subgroup. The concept of "functional precision medicine" involves gaining personalized insights on therapy choice, based on direct exposure of patient tissues to drugs. This especially holds promise for rare subtypes like low-grade serous ovarian cancer (LGSOC). This study aims to establish an in vivo model for LGSOC using zebrafish embryos, comparing treatment responses previously observed in mouse PDX models, cell lines and 3D tumor models. To address this goal, a well-characterized patient-derived LGSOC cell line with the

Identifiants

pubmed: 38791891
pii: cancers16101812
doi: 10.3390/cancers16101812
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Research Foundation - Flanders
ID : 1S73622N

Auteurs

Charlotte Fieuws (C)

Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Center for Medical Genetics Ghent, Ghent University Hospital, 9000 Ghent, Belgium.
Cancer Research Institute Ghent, 9000 Ghent, Belgium.

Jan Willem Bek (JW)

Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Center for Medical Genetics Ghent, Ghent University Hospital, 9000 Ghent, Belgium.
Cancer Research Institute Ghent, 9000 Ghent, Belgium.

Bram Parton (B)

Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Center for Medical Genetics Ghent, Ghent University Hospital, 9000 Ghent, Belgium.
Cancer Research Institute Ghent, 9000 Ghent, Belgium.

Elyne De Neef (E)

Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Center for Medical Genetics Ghent, Ghent University Hospital, 9000 Ghent, Belgium.
Cancer Research Institute Ghent, 9000 Ghent, Belgium.

Olivier De Wever (O)

Cancer Research Institute Ghent, 9000 Ghent, Belgium.
Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, 9000 Ghent, Belgium.

Milena Hoorne (M)

Cancer Research Institute Ghent, 9000 Ghent, Belgium.
Department of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.

Marta F Estrada (MF)

Champalimaud Centre of the Unknown, Champalimaud Foundation, 1400-038 Lisbon, Portugal.

Jo Van Dorpe (J)

Cancer Research Institute Ghent, 9000 Ghent, Belgium.
Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium.

Hannelore Denys (H)

Cancer Research Institute Ghent, 9000 Ghent, Belgium.
Department of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.

Koen Van de Vijver (K)

Cancer Research Institute Ghent, 9000 Ghent, Belgium.
Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium.

Kathleen B M Claes (KBM)

Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Center for Medical Genetics Ghent, Ghent University Hospital, 9000 Ghent, Belgium.
Cancer Research Institute Ghent, 9000 Ghent, Belgium.

Classifications MeSH